5-Chloro-6-fluoropyrazolo[1,5-a]pyrimidine

Catalog No. :
ACYQJA437
CAS No. :
1610021-36-7
Molecular Formula :
C6H3ClFN3
Molecular Weight :
171.56

IUPAC Name:5-chloro-6-fluoropyrazolo[1,5-a]pyrimidine

5-Chloro-6-fluoropyrazolo[1,5-a]pyrimidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$394.00Login to see priceIn stockInquiry
250mg97%$788.00Login to see priceIn stockInquiry
500mg97%$1312.00Login to see priceInquiryInquiry
1g97%$2187.00Login to see priceInquiryInquiry
5g97%$7416.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Chloro-6-fluoropyrazolo[1,5-a]pyrimidine
IUPAC Name5-chloro-6-fluoropyrazolo[1,5-a]pyrimidine
MDL No.MFCD28673863
Molecular FormulaC6H3ClFN3
Molecular Weight171.56
SMILESFC1=CN2C(N=C1Cl)=CC=N2
InChI KeyPWMLJGIPANYYKW-UHFFFAOYSA-N
Synonym5-chloro-6-fluoropyrazolo[1,5-a]pyrimidine | 1610021-36-7 | SCHEMBL15690188 | MFCD28673863 | AS-84478 | CS-0310446 | D79654
CAS No.1610021-36-7
PubChem CID90135474

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACYQJA437 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. ACGARQ594 route compound structure diagram
    ACGARQ5941610021-35-6 In Stock
  6. Then
  7. ACYQJA437 route product structure diagram
    ACYQJA4371610021-36-7 In Stock
Inquiry

2. ACYQJA437 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACYQJA437 route product structure diagram
    ACYQJA4371610021-36-7 In Stock
Inquiry

Comments (0)